2004
DOI: 10.1016/s1474-4422(04)00854-3
|View full text |Cite
|
Sign up to set email alerts
|

Treatments for dysarthria in Parkinson's disease

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

2
161
0
10

Year Published

2006
2006
2018
2018

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 251 publications
(173 citation statements)
references
References 135 publications
2
161
0
10
Order By: Relevance
“…It also suggests that antiparkinsonian medication reduces connectivity between left GPi and left PMd/LMC in PDN subjects, but not in PDSI subjects. Although levodopa provides effective treatment for motor symptoms in the early to moderate disease stages (Jankovic & Aguilar, 2008), the effect of levodopa on speech production is less consistent (Pinto et al., 2004; Schulz & Grant, 2000). If we consider hyperconnectivity of left GPi and left PMd/LMC to be a disease‐related phenomenon, it is possible that this pathological increase in connectivity contributes to speech impairments in PDSI subjects and is not responsive to levodopa in these individuals.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…It also suggests that antiparkinsonian medication reduces connectivity between left GPi and left PMd/LMC in PDN subjects, but not in PDSI subjects. Although levodopa provides effective treatment for motor symptoms in the early to moderate disease stages (Jankovic & Aguilar, 2008), the effect of levodopa on speech production is less consistent (Pinto et al., 2004; Schulz & Grant, 2000). If we consider hyperconnectivity of left GPi and left PMd/LMC to be a disease‐related phenomenon, it is possible that this pathological increase in connectivity contributes to speech impairments in PDSI subjects and is not responsive to levodopa in these individuals.…”
Section: Discussionmentioning
confidence: 99%
“…This resulted in a mixed group of subjects relative to PD medication use. Unlike limb motor symptoms, the effect of dopamine treatment on voice or speech is neither robust nor consistent (Pinto et al., 2004; Schulz & Grant, 2000). We thus chose to include both medicated and nonmedicated PD subjects.…”
Section: Methodsmentioning
confidence: 99%
“…The change in duration for the sustained vowel is reported in Figure 6 for each participant. Increases in duration post-therapy were minimal for five participants (3,8,10,11,9) and decreased in seven participants (4,6,12,1,5,2,7). Performance varied substantially across severity groups.…”
Section: Four Of the 12 Participants (4152) Demonstrated Modest Inmentioning
confidence: 94%
“…117,[119][120][121][122] Speech pathology intervention, in combination with an optimal medication regimen, is currently the most efficacious treatment for the dysarthria associated with PD. 10,44,112,123,124 In particular, there is evidence that the Lee Silverman Voice Treatment ® (LSVT LOUD hour per day, four days per week -across four weeks. 128 The treatment tasks are based on principles of motor learning and correspond to some of the proposed principles underlying neural plasticity, including intensity, complexity, saliency, early intervention, and ongoing activity to maintain function and avoid further deterioration.…”
Section: Behavioural Treatments Early Opinions Regarding Behaviouralmentioning
confidence: 99%
See 1 more Smart Citation